If you’ve been diagnosed with ductal carcinoma in situ (DCIS), you’ve likely encountered one of the most frustrating truths about this diagnosis: doctors still can’t say for certain whether your particular DCIS will stay put or eventually become invasive. That uncertainty drives real decisions — about surgery, radiation, hormone therapy — for the roughly 55,000 to 60,000 women diagnosed with DCIS in the U.S. each year. A new study offers a promising piece of the puzzle, and it comes from an unexpected direction: body weight.
Subscribe below for the latest DCIS news and updates.